6-MONTH OPEN TRIAL WITH ZIMELIDINE IN ALCOHOL-DEPENDENT PATIENTS - REDUCTION IN DAYS OF ALCOHOL INTAKE

Citation
J. Balldin et al., 6-MONTH OPEN TRIAL WITH ZIMELIDINE IN ALCOHOL-DEPENDENT PATIENTS - REDUCTION IN DAYS OF ALCOHOL INTAKE, Drug and alcohol dependence, 35(3), 1994, pp. 245-248
Citations number
10
Categorie Soggetti
Substance Abuse",Psychiatry
Journal title
ISSN journal
03768716
Volume
35
Issue
3
Year of publication
1994
Pages
245 - 248
Database
ISI
SICI code
0376-8716(1994)35:3<245:6OTWZI>2.0.ZU;2-L
Abstract
In an open study, 14 alcohol-dependent male patients were treated with the selective serotonin reuptake inhibitor (SSRI) Zimelidine, 200 mg daily, for six months. They were given psychosocial therapy before and during the study. The number of days of alcohol intake was statistica lly significantly reduced from a mean of 14 days per month before to 1 -5 days during drug treatment. No effect was observed on the amount of daily alcohol intake on drinking days. No tolerance to the effect of Zimelidine was observed during the study. The findings suggest an effe ct of combined psychosocial support with SSRI treatment that seems to be of clinical significance.